ArticleInternational journal of clinical oncology2025

Anti-HER2 plus endocrine therapy versus anti-HER2 plus chemotherapy in hormone receptor-positive and HER2-positive metastatic breast cancer: a retrospective study.

Zhenhua Fan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.